维普中文期刊产品整合服务
233篇 您的检索式:作者名="Ozdogan"
    题名 作者 年代 出处 被引量
1Partial virological response to three different nucleotide analogues in naive patients with chronic hepatitis B显示文摘BACKGROUND: The definition of partial virological response(PVR) was proposed because of its clinical relevance. PVR relates to subsequent therapeutic failure which results in the modification of the regimen. Whether this rationale can be applied to all nucleotide analogues (NA) is not clear. This study was undertaken to analyze PVR influence on therapeutic outcomes during lamivudine, entecavir or tenofovir mono therapy in NA-naive patients with chronic hepatitis B in routine clinical practice.METHODS: We retrospectively analyzed 150 NA-naive patients with chronic hepatitis B. These subjects received lamivudine entecavir or tenofovir monotherapy between February 2001 and July 2013.RESULTS: Sixty-nine patients were treated with lamivudine, 35with entecavir, and 46 with tenofovir. The median therapeutic duration was 19.5 (6-147) months. PVR rates at 24 weeks were similar among three NAs (lamivudine 33.3%, entecavir 35.0%tenofovir 32.4%, P=0.981). For all three NAs, patients with a higher baseline viral load or HBeA g-positive status had a higher serum viral positive rate tested by polymerase chain reaction at week 24 and 48. Cumulative probability of virological breakthrough (VBR) for patients treated with lamivudine was67% at 5 years, and PVR at 24 weeks was the independent risk factor for VBR (HR: 3.09; 95% CI: 1.09-8.74; P=0.034); also lamivudine treated patients older than 50 years seemed to have a tendency for VBR (HR: 2.80; 95% CI: 0.99-8.18; P=0.052)A majority of entecavir and tenofovir partial responders achieved and maintained virological response with prolonged monotherapy, except one entecavir treated patient who experienced VBR due to resistance mutations.CONCLUSIONS: Management strategy for lamivudine treatment should include adaptation of regimen according to PVR as an on-treatment response parameter due to its relation with unacceptably high VBR probability. Similar conclusion should not be directly related to entecavir or tenofovir treatment.Ender G Yegin Osman Cavit Ozdogan 2014Hepatobiliary & Pancreatic Diseases International2014,13,6:5
2Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis显示文摘Nonalcoholic fatty liver disease(NAFLD)remains a leading cause of chronic liver disease.In the context of NAFLD,the presence of nonalcoholic steatohepatitis (NASH)portends an adverse prognosis with greater risk of liver fibrosis and cirrhosis.Although liver biopsy is the keystone of patient management in NAFLD,it is also increasingly clear that such evaluation has its limitations.The availability of biochemical markers of NAFLD and NASH has tremendous potential to radically alter management strategies for these conditions,as well as to monitor disease activity.Our article provides an overview of biomarker discovery and selection in the setting of NAFLD and highlights future directions in the field.Yusuf Yilmaz Alla Eldeen Kedrah Osman Ozdogan 2009World Journal of Gastroenterology2009,15,35:4
3Spontaneous regres- sion of extruded lumbar disc herniation: report of two iUustrative case and review of the literature 显示文摘Sabuncuoglu H Ozdogan S Timurkaynak E 2008Turk Neurosurg2008,18,4:1
4Comparison between locked intramedullary nailing and plate osteosynthesis in the management of adult forearm fractures 显示文摘Ozkayz U Kilic A Ozdogan U 2009Acta Orthop Traumatol Turc2009,1,:1
5Langenbecks Arch Surg显示文摘Ozlem N Ozdogan M Gurer A Gomceli I Aydin R 0,,03:1
6Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease显示文摘Yusuf Yilmaz Oya Yonal Ramazan Kurt Yesim Ozen Alahdab Fatih Eren Osman Ozdogan Cigdem Ataizi Celikel Nese Imeryuz Cem Kalayci Erol Avsar 2011Scandinavian Journal of Gastroenterology2011,,1:1
7MELD score and clinical type predict prognosis in hepatorenal syndrome : relevance to liver transplantation显示文摘Alessartdria C Ozdogan O Guevara M 2005Hepatology2005,41,6:1
8Experimental study on charging and discharging periods of water in a latent heat storage unit显示文摘Mehmet Akif Ezan Muhammet Ozdogan Aytunq Erek 2011International Journal of Thermal Sciences2011,,50:1
9Thrombolysis via an operatively placed mesenteric catheter for portal and superior mesenteric vein thrombosis:report of a case显示文摘Ozdogan M Gurer A Gokakin AK 2006Surg Today2006,36,9:1
10Mild hypothermia improves survival during hemorrhagic shock without affecting bacterial translocation显示文摘Deniz T Agalar C Ozdogan M 2009J Invest Surg2009,22,1:1
11Beneficial effect of hyperbaric oxygenation on liver regeneration in cirrhosis显示文摘Ozdogan M Ersoy Z Dundar K 2005Journal of Surgical Research2005,129,2:1
12The mean platelet volume in patients with obesity显示文摘Coban E Ozdogan M Yazicioglu G 0,,08:1
13Prospective comparison of local, spinal, and general types of anaesthesia regarding oxidative stess following Lichtenstein hernia repair 显示文摘KULACOGLU H OZDOGAN M GURER A 2007Bratisl Lek Listy2007,108,8:1
14Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyper glycaemic mice显示文摘Erenmemisoglu A Ozdogan UK Saraymen R 1999J Pharm Pharmacol1999,51,6:1
15Estimation of CO2 emission factors of coals显示文摘OZDOGAN S 0,,14:1
16Transconjunetive 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment 显示文摘Altan T Acar N Kapran Z Unver YB Ozdogan S 2008Retina2008,28,9:1
17Variables affecting the occurrence of gastroesophageal reflux in obstructive sleep apnea patients显示文摘Ozturk 0 Ozturk L Ozdogan A 2004EurArch Otorhinolaryngol2004,261,4:1
18Assessment ofcardiac remodeling in asymptomatic mitral regurgitation for surgery timing:a comparativestudy of echocardiography and magnetic resonance imaging显示文摘Ozdogan O Yuksel A Gurgun C 2014Cardiovascular Ultrasound2014,13,4:1
19MELD score and clinical type predict prognosis in hepatorenal syndrome:relevance to liver trans-plantation显示文摘Alessandria C Ozdogan O Guevara M 2004Hepatology2004,41,:1
20Percutaneous liver biopsy complications in patients with chronic renal failure 显示文摘Ozdogan M Ozgur O Boyacioglu S 1996Nephron1996,74,2:1
返回顶部 每页显示:
共12页 首页 上一页 第1页 下一页 末页 /12 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费